Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W F Janssen

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Archives of Toxicology|February 17, 2021
Correction to: Cytochrome P450 expression, induction and activity in human induced pluripotent stem cell-derived intestinal organoids and comparison with primary human intestinal epithelial cells and Caco-2 cellsAafke W F Janssen, Loes P M Duivenvoorde, Deborah Rijkers, et al.
Archives of Toxicology|March 6, 2025
In vitro approaches to investigate the effect of chemicals on antibody production: the case study of PFASsMartina Iulini, Valeria Bettinsoli, Ambra Maddalon, et al.
Archives of Toxicology|April 23, 2026
Mechanistic insights into PFAS-induced effects on B lymphocyte activation and antibody secretionMartina Iulini, Karsten Beekmann, Ron L A P Hoogenboom, et al.
Frontiers in Toxicology|March 29, 2024
Determination of <i>in vitro</i> immunotoxic potencies of a series of perfluoralkylsubstances (PFASs) in human Namalwa B lymphocyte and human Jurkat T lymphocyte cellsAafke W F Janssen, Wendy Jansen Holleboom, Deborah Rijkers, et al.
Archives of Toxicology|November 3, 2022
Perfluoroalkyl substances (PFASs) decrease the expression of recombination-activating genes (RAG1 and RAG2) in human B lymphoma Namalwa cellsAafke W F Janssen, Jochem Louisse, Deborah Rijkers, et al.
Archives of Toxicology|August 31, 2024
Transport of perfluoroalkyl substances across human induced pluripotent stem cell-derived intestinal epithelial cells in comparison with primary human intestinal epithelial cells and Caco-2 cellsAafke W F Janssen, Loes P M Duivenvoorde, Karsten Beekmann, et al.
European Journal of Clinical Investigation|December 16, 2014
Necrostatin-1 alleviates reperfusion injury following acute myocardial infarction in pigsStefan Koudstaal, Martinus I F J Oerlemans, Tycho I G Van der Spoel, et al.
Journal of Hepatology|January 27, 2016
Gene expression profiling in human precision cut liver slices in response to the FXR agonist obeticholic acidNoortje Ijssennagger, Aafke W F Janssen, Alexandra Milona, et al.
Scientific Reports|November 3, 2024
Comparison of iPSC-derived human intestinal epithelial cells with Caco-2 cells and human in vivo data after exposure to Lactiplantibacillus plantarum WCFS1Aafke W F Janssen, Benthe van der Lugt, Loes P M Duivenvoorde, et al.
Journal of Lipid Research|May 24, 2017
Modulation of the gut microbiota impacts nonalcoholic fatty liver disease: a potential role for bile acidsAafke W F Janssen, Tom Houben, Saeed Katiraei, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Archives of Toxicology|February 17, 2021
Correction to: Cytochrome P450 expression, induction and activity in human induced pluripotent stem cell-derived intestinal organoids and comparison with primary human intestinal epithelial cells and Caco-2 cellsAafke W F Janssen, Loes P M Duivenvoorde, Deborah Rijkers, et al.
Archives of Toxicology|March 6, 2025
In vitro approaches to investigate the effect of chemicals on antibody production: the case study of PFASsMartina Iulini, Valeria Bettinsoli, Ambra Maddalon, et al.
Archives of Toxicology|April 23, 2026
Mechanistic insights into PFAS-induced effects on B lymphocyte activation and antibody secretionMartina Iulini, Karsten Beekmann, Ron L A P Hoogenboom, et al.
Frontiers in Toxicology|March 29, 2024
Determination of <i>in vitro</i> immunotoxic potencies of a series of perfluoralkylsubstances (PFASs) in human Namalwa B lymphocyte and human Jurkat T lymphocyte cellsAafke W F Janssen, Wendy Jansen Holleboom, Deborah Rijkers, et al.
Archives of Toxicology|November 3, 2022
Perfluoroalkyl substances (PFASs) decrease the expression of recombination-activating genes (RAG1 and RAG2) in human B lymphoma Namalwa cellsAafke W F Janssen, Jochem Louisse, Deborah Rijkers, et al.
Archives of Toxicology|August 31, 2024
Transport of perfluoroalkyl substances across human induced pluripotent stem cell-derived intestinal epithelial cells in comparison with primary human intestinal epithelial cells and Caco-2 cellsAafke W F Janssen, Loes P M Duivenvoorde, Karsten Beekmann, et al.
European Journal of Clinical Investigation|December 16, 2014
Necrostatin-1 alleviates reperfusion injury following acute myocardial infarction in pigsStefan Koudstaal, Martinus I F J Oerlemans, Tycho I G Van der Spoel, et al.
Journal of Hepatology|January 27, 2016
Gene expression profiling in human precision cut liver slices in response to the FXR agonist obeticholic acidNoortje Ijssennagger, Aafke W F Janssen, Alexandra Milona, et al.
Scientific Reports|November 3, 2024
Comparison of iPSC-derived human intestinal epithelial cells with Caco-2 cells and human in vivo data after exposure to Lactiplantibacillus plantarum WCFS1Aafke W F Janssen, Benthe van der Lugt, Loes P M Duivenvoorde, et al.
Journal of Lipid Research|May 24, 2017
Modulation of the gut microbiota impacts nonalcoholic fatty liver disease: a potential role for bile acidsAafke W F Janssen, Tom Houben, Saeed Katiraei, et al.
Pageof 4